Navigation Links
VDEX Diabetes Releases White Paper on Afrezza and Recommends New Treatment Protocol For Type 1 and Type 2 Diabetes.
Date:8/2/2017

Los Angeles, July 31, 2017. VDEX Diabetes, an operator of specialized diabetes treatment centers, announced today the public release of its White Paper on Afrezza, a new form of insulin created by MannKind Corporation, and a new treatment protocol for Type 1 and Type 2 diabetics. Vdex’ White, Paper is the result of a 12-month investigation of Afrezza that assessed the product from the perspective of safety, efficacy, relative utility, and usage guidelines. As a result of that investigation, Vdex is recommending a new treatment paradigm for all people with diabetes. Through the use of this new paradigm, Vdex claims, people will have far better control of their blood sugar levels with far less risk.

“Afrezza was an intriguing product about which there were widely divergent opinions, so we felt it was necessary to learn for ourselves the facts of the product. For that reason, we conducted extensive studies that ultimately evolved into the White Paper,” commented William McCullough, CEO and Founder of Vdex Diabetes.

MannKind received FDA approval for Afrezza in mid-2014 and launched the product in early 2015. Sales have been disappointing despite the effusive claims of some users. Vdex Diabetes was founded in 2015 in Los Angeles, California and currently operates several treatment facilities in the Los Angeles area.

“The disease of diabetes has been crying out for years for some new treatment that would measurably improve the care for people with the disease. It appears Afrezza is the answer. It’s far safer, more effective and much more convenient than any other insulin,” continued McCullough.

The VDEX White Paper recommends a new treatment protocol for diabetes described as “Afrezza First, Afrezza Instead, Afrezza always.” This protocol is a very significant change from the current recommendations of the American Diabetes Association.

“In recommending the new treatment protocol, we simply went where the facts took us. We just wanted to figure out where Afrezza fit among all the existing treatments. It turns out our conclusion is that Afrezza upends the entire slate of treatments. We were surprised by where we ended up,” added McCullough.

Diabetes is a disease that effects more than 1 billion people. Estimates put the worldwide incidence at over 400 million with diabetes and another 800 million “prediabetic.” VDEX contends that prediabetes is “early-stage diabetes.”

The White Paper can be found at Vdex’ website, vdexdiabetes.com.

Contact: Stephen Brown
818-661-6367
info(at)vdexdiabetes.com

Read the full story at http://www.prweb.com/releases/2017/8/prweb14561200.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. ZyDoc Chairman James M. Maisel, MD Presents “Using NLP to Identify and Manage Patient Populations at Risk for Diabetes and Complications” at 5th World Diabetes Congress
2. ZyDoc Chairman James M. Maisel, MD Chairs the Epidemiology and Prevention of Diabetes Section at the 5th World Congress of Diabetes 2017 in Prague, Czech Republic
3. Team Type 1 Foundation Announces Over 100 Scholarships to Collegiate Athletes with Diabetes
4. CS3 Technology Raising Funds to Stop Diabetes
5. Boehringer Ingelheim and Eli Lilly Show Commitment to Women with Diabetes at 2017 DiabetesSisters Leadership Institute
6. Take One Minute to Protect Health by Taking the Type 2 Diabetes Risk Test
7. Alert Day: American Diabetes Association Call To Action
8. AJMC®’s Evidence-Based Diabetes Management™ Publishes Special Lifestyle Issue
9. Houston Dentist, Dr. Behzad Nazari, Comments on the Recent Study Linking Gum Disease to Type 2 Diabetes
10. AIS Health, Mom’s Meals NourishCare Partner for Upcoming Webinar on the Role Nutrition Plays Post Discharge and in Managing Diabetes
11. McDonnell Focus of 20th Annual Los Angeles Political Roast Benefiting American Diabetes Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2020)... ... July 07, 2020 , ... Great Point Partners (“GPP”) today announced that the ... appointed Rick Katz as Vice President of Business Development. , "After a comprehensive ... this leadership role for the organization," said Adam Elberg, chairman of the Spine & ...
(Date:7/4/2020)... ... July 03, 2020 , ... The latest SARS-CoV-2 news, enabling ... Future Lab: COVID-19 R&D . , Future Lab is an interactive ... specific scientific niches. Since their launch four years ago, the Future Lab content ...
(Date:7/4/2020)... ... July 03, 2020 , ... MemoryCare.com , a comprehensive ... Best Memory Care Facilities in Charleston, South Carolina. The guide identifies 5 memory ... , According to the Alzheimer’s Association , 5.6 million people age 65 ...
(Date:7/2/2020)... (PRWEB) , ... July 02, 2020 , ... Dr. ... York plastic and cosmetic surgeons, with medical offices located in Staten Island, Huntington and ... be relocating to a beautifully designed medical suite at The Parlor NYC at 160 ...
(Date:7/2/2020)... ... 02, 2020 , ... Allegheny Health Network (AHN) today announced that John S. ... effective immediately. Dr. Lee succeeds Robert White, MD, who announced his plans for ... the year to help support a seamless transition. , Dr. Lee joins AHN from ...
Breaking Medicine News(10 mins):
(Date:7/7/2020)... ... July 07, 2020 , ... SupplyPro announces a Contact Tracing function available on ... every one of us. SupplyPro is dedicated to supporting the worldwide response to COVID-19. ... Report - a powerful tool in the fight against the spread of COVID-19. ...
(Date:7/2/2020)... ... July 02, 2020 , ... AllenComm, the leader in ... four Omni Awards for visually compelling compliance training , onboarding , ... and exceed client and industry expectations as a digital transformation partner for learning and ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... is pleased to announce its donation of more than $190,000 in personal protective ... Health and Human Services. As extreme medical shortages continue to plague the nation’s ...
Breaking Medicine Technology: